# FDA recall D-690-2013

> **Teva Pharmaceuticals USA, Inc.** · Class III · drug recall initiated 2013-03-15.

## Product

Camila (norethindrone tablets, USP), 0.35 mg, 6 blister cards per carton, 28 tablets each, 28 day regimen, Rx Only, Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 0555-0715-58

## Reason for recall

Failed Impurity/Degradation Specification; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) was detected during impurity testing

## Distribution

Nationwide and Puerto Rico

## Key facts

- **Recall number:** D-690-2013
- **Recalling firm:** Teva Pharmaceuticals USA, Inc.
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-03-15
- **Report date:** 2013-07-17
- **Termination date:** 2014-01-15

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Sellersville, PA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-690-2013

## Citation

> AI Analytics. FDA recall D-690-2013. Retrieved 2026-05-26 from https://api.ai-analytics.org/recall/D-690-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*